Table 1.
Qualitative (subjective) measures | Quantitative (objective) measures |
• Self-report using MMAS-4 or -8a • Self-report using other standardized questionnaires or surveys, such as SDSCA or MARS • Patient-reported subjective assessment of adherence (eg, in response to a simple, nonjudgmental question from the health care provider, such as “How often do you miss taking your medication?”) • Provider-reported subjective assessment of adherence (eg, based on clinical response and/or laboratory results, such as HbA1c) • Patient diaries or computerized logbooks • Mobile phone real-time assessment |
• MPRb (or variations of MPR, such as PDCc), usually assessed using pharmacy-claim databases • Pill counts • Electronic monitoring devices (eg, MEMS) • Biochemical measurement using nontoxic biological marker • Measurement of concentrations of a drug or its metabolite in blood or urine |
Notes:
Provide an adherence score by summing responses (yes = 0, no = 1) to MMAS items; higher scores indicate better adherence.16
Number of days of medication supplied within prescription-refill period divided by number of days in refill period.16,19
Number of days with drug on hand divided by number of days in specified time interval.83 Data from these studies.4,10,12,14,15,17,18
Abbreviations: HbA1c, glycosylated hemoglobin; MARS, Medication Adherence Report Scale; MEMS, medication event-monitoring system; MMAS, Morisky Medication Adherence Scale; MPR, medication-possession ratio; PDC, proportion of days covered; SDSCA, Summary of Diabetes Self-Care Activities. Adherence to antihyperglycemic medication